Micrococcus infection in patients receiving epoprostenol by continuous infusion.
Yap
R L
RL
Division of Infectious Diseases, Department of Medicine, Brown Medical School and Rhode Island Hospital, 593 Eddy Street, Providence, RI 02903, USA.
Mermel
L A
LA
D000328:Adult; D000368:Aged; D000959:Antihypertensive Agents / Q000009:adverse effects / Q000627:therapeutic use; D002408:Catheters, Indwelling / Q000009:adverse effects* / Q000382:microbiology; D015331:Cohort Studies; D011464:Epoprostenol / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D016908:Gram-Positive Bacterial Infections / Q000175:diagnosis* / Q000453:epidemiology / Q000209:etiology; D006801:Humans; D006976:Hypertension, Pulmonary / Q000175:diagnosis / Q000188:drug therapy*; D015994:Incidence; D007262:Infusions, Intravenous; D008297:Male; D008837:Micrococcus / Q000302:isolation & purification*; D008875:Middle Aged; D012189:Retrospective Studies; D018570:Risk Assessment
D000959:Antihypertensive Agents; D011464:Epoprostenol